Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Cécile Torregrosa"'
Autor:
Cécile Torregrosa, Simon Pernot, Pauline Vaflard, Audrey Perret, Christophe Tournigand, Violaine Randrian, Solene Doat, Cindy Neuzillet, Valérie Moulin, Morgane Stouvenot, Gael Roth, Tiffany Darbas, Benjamin Auberger, Tiphaine Godet, Marion Jaffrelot, Aurélien Lambert, Olivier Dubreuil, Cassandre Gluszak, Alice Bernard‐Tessier, Anthony Turpin, Lola‐Jade Palmieri, Olivier Bouche, Gael Goujon, Thierry Lecomte, David Sefrioui, Christophe Locher, Lucien Grados, Pauline Gignoux, Stéphanie Trager, Elise Nassif, Angélique Saint, Pascal Hammel, Cédric Lecaille, Mathilde Bureau, Marine Perrier, Damien Botsen, Vincent Bourgeois, Julien Taieb, Edouard Auclin
Publikováno v:
International Journal of Cancer. 151:1978-1988
Publikováno v:
médecine/sciences
médecine/sciences, EDP Sciences, 2020, 36 (11), pp.1054-1058. ⟨10.1051/medsci/2020188⟩
médecine/sciences, EDP Sciences, 2020, 36 (11), pp.1054-1058. ⟨10.1051/medsci/2020188⟩
Le termeincidentalome, créé en 1982, s’est, depuis, diffusé dans la littérature médicale. Il ne semble cependant pas exister de définition précise pour décrire ce qu’est un incidentalome. Dans les usages initiaux, l’incidentalome désig
Autor:
Cécile Torregrosa, Frédéric Chorin, Eva Ester Molina Beltran, Cindy Neuzillet, Victoire Cardot-Ruffino
Publikováno v:
Cancers. 14:5402
Multidisciplinary supportive care, integrating the dimensions of exercise alongside oncological treatments, is now regarded as a new paradigm to improve patient survival and quality of life. Its impact is important on the factors that control tumor d
Publikováno v:
Medecine sciences : M/S. 36(11)
The term incidentaloma, created in 1982, has spread throughout medical literature. However, there does not seem to be a precise definition to describe what an incidentaloma is. In the initial uses, the word incidentaloma systematically designated a m
Autor:
Thierry André, Romain Cohen, Daniel Lopez-Trabada, Stéphane Ederhy, Pauline Vaflard, Cécile Torregrosa
Publikováno v:
Bulletin du Cancer. 105:707-719
The incidence of cardiac toxicity of 5-flurorouracil (5-FU) IV and capecitabine varies from 1.2 to 18%. The physiopathology of this toxicity is still under study, various hypotheses are mentioned. In the absence of identified prophylactic treatment,
Autor:
Philippe Rousselot, Pauline Vaflard, Cécile Torregrosa, Christine Terré, Julien Moroch, Diane Lara, Jeanne Chen, Juliette Lambert, Solene Houlle-Crepin, Isabel Garcia
Publikováno v:
Hématologie. 23:135-143
Le syndrome 8p11 est un syndrome rare dont le pronostic defavorable est du a une progression rapide vers une leucemie aigue myeloide (LAM) ou vers un lymphome lymphoblastique. Il resulte d’une mutation acquise impliquant le gene FGFR1 situe en p11
Autor:
Pauline, Vaflard, Stéphane, Ederhy, Cécile, Torregrosa, Thierry, André, Romain, Cohen, Daniel, Lopez-Trabada
Publikováno v:
Bulletin du cancer. 105(7-8)
The incidence of cardiac toxicity of 5-flurorouracil (5-FU) IV and capecitabine varies from 1.2 to 18%. The physiopathology of this toxicity is still under study, various hypotheses are mentioned. In the absence of identified prophylactic treatment,